NEVVI Medicare utilization intelligence
or

← back

Provider profile

JAIN, SHARAD MD

Hematology-Oncology · NPI 1467494385 · DENTON, TX

1
Groups
55
Codes · 2024
58,007
Disclosed services

JAIN, SHARAD is a Hematology-Oncology in DENTON, TX, a member of 1 medical group, who billed 55 distinct codes to Medicare Part B in 2024.

Groups: TEXAS ONCOLOGY PA (DALLAS, TX)

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

58,007
disclosed services
55
codes billed to Medicare Part B
Prior year · CY2023 83,167 disclosed services

This provider's disclosed Medicare payments across all codes were in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J1756 Injection, iron sucrose, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J1453 Injection, fosaprepitant, 1 mg
J0897 Injection, denosumab, 1 mg
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
83615 Lactate dehydrogenase (enzyme) level
J1100 Injection, dexamethasone sodium phosphate, 1 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J1626 Injection, granisetron hydrochloride, 100 mcg
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
J2469 Injection, palonosetron hcl, 25 mcg
M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services
96372 Injection of drug or substance under skin or into muscle
96375 Injection of additional new drug or substance into vein
96413 Administration of chemotherapy into vein, 1 hour or less
J3475 Injection, magnesium sulfate, per 500 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
J3489 Injection, zoledronic acid, 1 mg
85007 Microscopic examination for white blood cells with manual cell count
85027 Complete blood cell count (red cells, white blood cell, platelets), automated test
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
85055 Reticulated (young) platelet measurement
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
80048 Blood test, basic group of blood chemicals (calcium, total)
71260 Ct scan of chest with contrast
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96523 Irrigation of implanted venous access drug delivery device
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
84550 Uric acid level, blood
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
J1200 Injection, diphenhydramine hcl, up to 50 mg
74177 Ct scan of abdomen and pelvis with contrast
J7030 Infusion, normal saline solution , 1000 cc
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
96417 Administration of additional new drug or substance into vein, 1 hour or less
71250 Ct scan of chest without contrast
82565 Blood creatinine level
84520 Urea nitrogen level to assess kidney function, quantitative
96374 Injection of drug or substance into vein
74176 Ct scan of abdomen and pelvis without contrast
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96415 Administration of chemotherapy into vein, each additional hour
85046 Red blood count automated, with additional calculations
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
96360 Infusion into a vein for hydration, 31-60 minutes
83735 Magnesium level
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.